Partition of metabolizable energy, and prediction of growth performance and lipid deposition in broiler chickens

The study presented here consisted of the calculation of cross relationships between growth performance parameters, body growth composition, and feed characteristics, using data from an experiment reported in 2 previous publications. In the previous experiment, 30 pelleted diets were given to broiler chickens (8/diet) (21 to 35 d) for in vivo measurement and prediction of AMEn and net energy (NE) values of diets, using 3 trials with 10 diets/trial. In the course of NE determination, individual values for growth, feed intake, and deposition of lipid and protein were measured. Average energy deposited as lipid and protein represented 25.4 and 19.1% AME intake, respectively. Using a multiple regression predicting AME intake, the partial efficiencies of AME for energy deposition as lipid and protein were calculated to be 91.6 and 67.3%, respectively, and the daily amount of AME required for maintenance was evaluated at 0.683 MJ/kg BW0.7. The mean diet NE/AMEn ratios were predicted by an equation combining the lipid content of body growth (positive coefficient) and the apparent digestible protein (ADP) to AMEn ratio (ADP/AMEn), with a quadratic expression for the latter variable. This quadratic response expressed a positive asymptotic relationship, with a plateau for ADP/AMEn values above 1.45 [%/(MJ/kg)]. The equations predicting growth always included either the dietary percentage of water-insoluble cell wall or the AMEn value. The other major parameters predicting growth were either the lipid content of body growth or the CP/AMEn ratio. In many cases, quadratic responses were observed in growth prediction equations. Regressions predicting feed efficiency showed only linear responses. Feed efficiency was predicted precisely by multiple linear regressions based only on AMEn and a dietary protein parameter. According to these regressions, 1% CP was equivalent to 0.247 MJ/kg AMEn in terms of feed efficiency. The most efficient regression predicting the individual lipid content of body growth combined the protein efficiency value (negative coefficient), the CP/AMEn ratio (negative coefficient), AMEn (positive coefficient), and the feather content of body growth (positive coefficient).

Botanical alternatives to antibiotics for use in organic poultry production

The development of antibiotic resistant pathogens has resulted from the use of sub-therapeutic concentrations of antibiotics delivered in poultry feed. Furthermore, there are a number of consumer concerns regarding the use of antibiotics in food animals including residue contamination of poultry products and antibiotic resistant bacterial pathogens. These issues have resulted in recommendations to reduce the use of antibiotics as growth promoters in livestock in the United States. Unlike conventional production, organic systems are not permitted to use antibiotics. Thus, both conventional and organic poultry production need alternative methods to improve growth and performance of poultry. Herbs, spices, and various other plant extracts are being evaluated as alternatives to antibiotics and some do have growth promoting effects, antimicrobial properties, and other health-related benefits. This review aims to provide an overview of herbs, spices, and plant extracts, currently defined as phytobiotics as potential feed additives.

Chemistry and multibeneficial bioactivities of carvacrol (4-isopropyl-2-methylphenol), a component of essential oils produced by aromatic plants and spices

Aromatic plants produce organic compounds that may be involved in the defense of plants against phytopathogenic insects, bacteria, fungi, and viruses. One of these compounds, called carvacrol, which is found in high concentrations in essential oils such as oregano, has been reported to exhibit numerous bioactivities in cells and animals. This integrated overview surveys and interprets our present knowledge of the chemistry and analysis of carvacrol and its beneficial bioactivities. These activities include its antioxidative properties in food (e.g., lard, sunflower oil) and in vivo and the inhibition of foodborne and human antibiotic-susceptible and antibiotic-resistant pathogenic bacteria, viruses, pathogenic fungi and parasites, and insects in vitro and in human foods (e.g., apple juice, eggs, leafy greens, meat and poultry products, milk, oysters) and food animal feeds and wastes. Also covered are inhibitions of microbial and fungal toxin production and the anti-inflammatory, analgesic, antiarthritic, antiallergic, anticarcinogenic, antidiabetic, cardioprotective, gastroprotective, hepatoprotective, and neuroprotective properties of carvacrol as well as metabolic, synergistic, and mechanistic aspects. Areas for future research are also suggested. The collated information and suggested research might contribute to a better understanding of agronomical, biosynthetic, chemical, physiological, and cellular mechanisms of the described health-promoting effects of carvacrol, and facilitate and guide further studies needed to optimize the use of carvacrol as a multifunctional food in pure and encapsulated forms, in edible antimicrobial films, and in combination with plant-derived and medical antibiotics to help prevent or treat animal and human diseases.